Gainers
- iSpecimen ISPC stock rose 33.3% to $3.8 during Friday's pre-market session. The company's market cap stands at $3.6 million.
- NAYA Biosciences NAYA stock rose 22.02% to $0.51. The company's market cap stands at $2.5 million.
- Avenue Therapeutics ATXI shares increased by 14.28% to $2.0. The market value of their outstanding shares is at $4.1 million.
- Vincerx Pharma VINC stock increased by 11.13% to $0.16. The company's market cap stands at $5.6 million.
- VSee Health VSEE stock rose 9.92% to $1.55. The market value of their outstanding shares is at $24.2 million.
- OnKure Therapeutics OKUR stock increased by 9.81% to $6.6. The market value of their outstanding shares is at $88.0 million.
Losers
- Champions Oncology CSBR stock decreased by 12.5% to $8.71 during Friday's pre-market session. The company's market cap stands at $119.3 million.
- QT Imaging Holdings QTI shares declined by 10.23% to $0.47. The market value of their outstanding shares is at $10.3 million.
- Oragenics OGEN shares declined by 9.4% to $0.27. The market value of their outstanding shares is at $3.3 million.
- Know Labs KNW shares decreased by 8.79% to $0.13. The company's market cap stands at $13.7 million.
- Venus Concept VERO shares decreased by 8.11% to $0.34. The market value of their outstanding shares is at $2.4 million.
- Zhengye Biotechnology ZYBT stock declined by 7.68% to $4.33. The company's market cap stands at $204.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
CSBRChampions Oncology Inc
$9.75-2.01%
ISPCiSpecimen Inc
$3.7732.3%
KNWKnow Labs Inc
$0.1256-8.79%
NAYANAYA Biosciences
$0.514722.0%
OGENOragenics Inc
$0.2700-9.40%
OKUROnKure Therapeutics Inc
$6.609.82%
QTIQT Imaging Holdings Inc
$0.5033-4.35%
VEROVenus Concept Inc
$0.3400-8.11%
VINCVincerx Pharma Inc
$0.155911.3%
VSEEVSee Health Inc
$1.559.93%
ZYBTZhengye Biotechnology Holding Ltd
$4.33-7.68%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in